News

The collaboration, also supported by the Biologics Delivery Systems Group of Cordis Corporation, will focus on dosing, delivery and targeting of the ViaCell stem cells using Cordis’ NOGA

Wellbutrin XL is the first and only medication approved to prevent seasonal major depressive episodes. Although antidepressant medications have been used to treat acute seasonal major depressive episodes

The deal involves four Discovery Partners International (DPI) sites in the US, Germany, and Switzerland which will be merged into BioFocus, the drug discovery services division of Galapagos.

The research involved leptin, the hormone that turns off hunger but fails to cross into the brain to regulate appetite in obese people. According to Dr Susan Farr,

The priority review designation means that the FDA will try to complete its review of the drug within six months, rather than the usual nine. The designation was

In the phase IIb study, HIV-infected patients failing their current antiretroviral therapy will receive oral bevirimat or placebo once daily for three months in combination with background antiretroviral

The phase IIa trial, to be conducted at the Royal Adelaide Hospital in Australia, will evaluate the drug primarily in patients suffering from diabetic neuropathy. The dose-escalating trial

The companies will jointly select five targets, including targets with the potential to raise “good cholesterol”, for development with PTC’s GEMS (gene expression modulation by small-molecules) technology. The

MicroRNAs (miRNAs) are a recently discovered class of natural antisense RNAs that are important in the regulation of cellular functions. These data demonstrate that antisense inhibition is a